background: Singletons born after IVF have an adverse perinatal outcome when compared with singletons in the general population.
Introduction
Improved perinatal outcome for children born after IVF has been shown in recent studies (Källen et al., 2010a; Sazonova et al., 2011) . In Sweden, this improvement can be attributed, to a certain extent, to single embryo transfer (SET) and thus lower rates of multiple births (Thurin et al., 2004; Thurin-Kjellberg et al., 2006; Källen et al., 2010a; Sazonova et al., 2011) .
The increased risks for adverse obstetric outcome in IVF pregnancies cannot, however, be explained entirely by the high incidence of multiple births. In numerous previous studies, it has been demonstrated that not only children in multiple births but also singletons after IVF have a poorer outcome, compared with singletons in the general population (Klemetti et al., 2002 (Klemetti et al., , 2006 Helmerhorst et al., 2004; Jackson et al., 2004; McDonald et al., 2009; McGovern et al., 2004; Schieve et al., 2004 Schieve et al., , 2007 . Even after adjustments for maternal factors such as age, parity, duration of infertility, smoking and BMI, known to influence the outcome, significantly higher rates of preterm delivery and low birthweight (LBW) were observed for IVF singletons (Bergh et al., 1999; Sazonova et al., 2011) . The cause of this increased risk is not fully understood, but for safety reasons it is of utmost importance to elucidate this question. It has been discussed that the hormonal stimulation in itself and also the in vitro culture could be an explanation. An intriguing finding was that singletons born after the vanishing of one gestational sac have a less favourable obstetric outcome than singletons where only one sac was identified from the outset (Pinborg et al., 2007) . Obstetric complications, such as preeclampsia, placental abruption and placenta previa, also occur more frequently in IVF pregnancies, even when only singleton pregnancies are compared with pregnancies after spontaneous conception (Jackson et al., 2004; Källen et al., 2005a; Shevell et al., 2005; Romundstad et al., 2006; Schieve et al., 2007; Healy et al., 2010; Källen et al., 2010a ) and irrespective of SET or double embryo transfer (DET) (Sazonova et al., 2011) .
The aim of this study was to investigate maternal and IVF-treatment-related variables, for possible influence on obstetric outcomes in IVF singletons.
Materials and Methods
Data were collected from all IVF clinics in Sweden, both public and private, for all IVF treatments during the years 2002 -2006 . Data collected from the IVF clinics included: mother identification, type of IVF treatment (fresh, frozen, IVF, ICSI, ejaculated sperm, epididymal sperm and testicular sperm), donated/own oocytes, number of oocytes retrieved, cleavage stage transfer, blastocyst stage transfer, date of embryo transfer, number of embryos transferred, number of frozen embryos, number of gestational sacs at ultrasound and date for ultrasound, date of delivery and number of children born.
All reported IVF singletons from fresh cycles using the couples' own gametes were included. Singletons were grouped according to embryo transfer characteristics: elective SET (eSET), non-eSET, DET resulting in one sac and DET resulting in more than one sac, so-called 'vanishing twin'. This subdivision was done from a clinical perspective and on the basis of a discussion in recent years concerning a possible difference in outcome for singletons depending on the number of embryos transferred. eSET was defined as transfer of one fresh embryo, when in the same treatment cycle, at least one embryo was cryopreserved. Non-eSET was defined as fresh cycles when one embryo was transferred and no embryos were cryopreserved.
In Sweden, IVF is both publicly and privately funded. Publicly funded IVF is offered to childless couples after investigation, which is performed after at least 1 year of infertility and if no other treatment is considered suitable. Certain age limits exist, usually 40 years for women. Exact rules differ somewhat between different regions. Up to three subsidized cycles with fresh embryos are offered in most regions. After achieving a live birth, no more publicly funded cycles are offered.
Using each individual's unique personal identity number, the data from the IVF clinics were cross-linked with the Swedish Medical Birth Registry (National Board of Health and Welfare, 2003) from which obstetric outcomes were retrieved. The Swedish Medical Birth Registry has been found to have high validity and includes virtually all deliveries in Sweden (Cnattingius et al., 1990, National Board of Health and Welfare, 2003) . Every person in Sweden is given a unique identification number, minimizing the risk of mistakes in the registries.
Main outcome measures were: very preterm birth (,32 weeks of gestation), small for gestational age (SGA), defined as more than two SDs below the Swedish gestational age-and gender-specific growth standard (Marsal et al., 1996) , placenta previa (diagnosed at delivery) (international classification of disease, ICD 10 code O.44) and placental abruption (ICD 10 code O.45). Secondary outcomes were ,28 weeks of gestation, ,37 weeks of gestation, mean gestational age, very LBW (,1500 g) and LBW (,2500 g), mean birthweight, mean SD scores (z-scores), perinatal mortality, pre-eclampsia (ICD 10 codes O.14, O.15), gestational diabetes (ICD code O.24.4) and preterm premature rupture of the membranes (ICD 10 code O.42).
Gestational age was, for this particular study, determined according to the day of embryo transfer and number of days in culture. Blastocyst transfer was performed in a minority of the cycles and it was not possible to elucidate the exact reasons for whether blastocyst transfer or cleavage stage transfer was performed. Since blastocyst transfer might affect the outcomes, adjustments for transfer of blastocyst or cleavage-stage embryos were made in the analysis. Transfer of cleavage-stage embryos (Day 2) was calculated as Day 16 and transfer of blastocysts (Day 5) was calculated as Day 19. The day for oocyte retrieval was assessed as Day 14 and adding 2 and 5 days will give Day 16 and 19, respectively. This was regarded as appropriate since all statistical comparisons in this report were performed within the IVF cohort and the day of embryo transfer was assumed to give a more precise dating of gestation than second trimester ultrasonography. Weight at birth was calculated as SDs (z-scores) from expected mean birthweight according to gestational age and gender in a Swedish reference cohort (Marsal et al., 1996) .
Perinatal mortality was defined as intrauterine death after 28 completed weeks of gestation, and early neonatal death within one week of birth.
Ethical approval
Approval was obtained from the Ethics committee of the University of Gothenburg.
Statistical methods
Descriptive data are given as numbers and percentages. Risk factor analysis for the main obstetric outcomes [very preterm birth (,32 weeks), SGA, placenta previa and placental abruption] was performed by logistic regression analysis. Crude odds ratios (OR) and adjusted OR (AOR) with 95% confidence intervals (CIs) were calculated using Gauss (Gauss TM , Aptech Systems Inc., Maple Valley, WA, USA, http://www. aptech.com).
The Kruskal -Wallis non-parametric test was used to compare continuous variables between the study groups. The primary variables of the investigation were:
(1) eSET, non-eSET, DET and vanishing twin (DET with more than one sac at first trimester sonography, i.e. two embryos implanted but only one child born), (expressed as binary variables with eSET as the reference group). (2) Blastocyst (yes/no).
The following factors were expected to be associated with the four main outcomes as well as with the primary variables of the investigation. They were therefore regarded as possible confounders and were tested for independent prediction:
(1) Maternal age (entered to the analyses as a linear, continuous variable or for some outcomes where a u-shaped association with maternal age was detected, as a second degree polynomia as specified in the results). ] (expressed as a linear, continuous variable or for some outcomes, where a u-shaped association with BMI was detected, as a second degree polynomia as specified in the results). In the multiple models, missing information was replaced by the overall mean BMI (¼24.7). (4) Duration of infertility (number of years) (expressed as a linear, continuous variable). (5) Maternal smoking in the first trimester (expressed as a quasicontinuous variable; 1 ¼ no smoking, 2 ¼ smoking 1 -9 cigarettes per day, 3 ¼ smoking ≥ 10 cigarettes per day). In the multiple models, missing smoking information was replaced by the overall mean (¼1.04 in the semi-continuous scale). (6) Number of aspirated oocytes (expressed as a linear, continuous variable). (7) Number of embryos frozen (expressed as a linear, continuous variable) in that particular cycle.
In order to determine which other variables should enter the final multiple logistic regression models, the following steps were taken: First, the best Factors affecting obstetric outcome for IVF singletons logistic model for each investigated variable (linear, quadratic or divided into designed class variables) was determined by investigating the level of significance and goodness of fit according to the Hosmer-Lemoshow test. If a u-shaped relationship was identified, the variable in question was represented by one linear and one quadratic term (second-grade polynomial). The resulting final univariate model for each investigated factor is described earlier. Vanishing twin, non-eSET, DET with one sac and blastocyst transfer were regarded as the key variables of interest (see earlier-mentioned text), and were thus included in the final models regardless of their significance level. For the other considered factors, variables with P-values below 0.20 in the final univariate models were initially included in the multivariable models, and then excluded if the P-values exceeded 0.20 in the multivariable analysis. In order to minimize the risk for over-fitted models, the number of investigated factors never exceeded 1/10 of the number of outcome events. Statistical significance was set at P , 0.05.
Results
Maternal characteristics and IVF-technique-related variables for singletons born after eSET, non-eSET, DET with one sac and DET with vanishing twin are described in Table I . In total, 8941 singletons were born after fresh transfer with the couples' own gametes (49% after IVF and 51% after ICSI): 4191 infants after eSET, 1860 infants after non-eSET, 2715 infants after DET one sac and 175 infants after DET with vanishing twin Obstetric outcomes for the four groups are described in Table II . Mean birthweight differed significantly between groups, with the lowest birthweight for singletons from 'vanishing twin' pregnancies. In Table III , obstetric outcome for blastocyst and cleavage stage transfers are presented.
Very preterm birth, less than 32 weeks of gestation Primiparity (AOR 2.52; 95% CI 1.51 -4.20), maternal smoking (AOR 1.71; 95% CI 1.02 -2.85), BMI (AOR 1.05; 95% CI 1.01 -1.10) and 'vanishing twin' (2.47; 95% CI 1.03-5.96) (with eSET as reference) were independently associated with very preterm birth (,32 weeks) (Table IV) . No association was found between non-eSET and DET one sac (with eSET as reference) and very preterm birth (,32 weeks). No significant association was found for blastocyst transfer, number of eggs retrieved or number of embryos cryopreserved.
Small for gestational age
Maternal age (AOR 1.04; 95% CI 1.01 -1.07), primiparity (AOR 1.99; 95% CI 1.43 -2.75), maternal smoking (AOR 1.57; 95% CI 1.06 -2.34) and years of infertility (AOR 1.07; 95% CI 1.02 -1.13) were positively associated with SGA, while a u-shaped association was found between BMI and SGA (P ¼ 0.0223) (Table IV) . Therefore, BMI was entered as a second-degree polynomia in the logistic regression analysis. The overall u-shape was statistically significant. When analysing BMI using class variables, high as well as low BMI values increased the risk for SGA compared with a normal BMI (20-25 kg/m 2 ); however, this was only significant for low BMI (data not shown). No association with SGA was found for the number of embryos transferred, number of embryos cryopreserved or blastocyst transfer.
Placenta previa
Maternal age (AOR 1.06; 95% CI 1.01-1.11) and blastocyst transfer (AOR 2.23; 95% CI 1.51-3.29) were positively associated, while primiparity was negatively associated (AOR 0.51; 95% CI 0.36 -0.72) with placenta previa (Table V) .
Placental abruption
Smoking was the only variable significantly associated with placental abruption (AOR 1.94; 95% CI 1.02 -3.67) ( Table V) .
Discussion
This large registry study of singletons born after IVF cycles using own oocytes with fresh embryos found that the maternal characteristics such as age, smoking, primiparity, BMI and duration of infertility were significantly associated with a poorer obstetric outcome for the children when assessed as one or both of two selected obstetric outcomes, very preterm birth (,32 weeks) and SGA. These two specific outcomes were selected since they were regarded as important and robust. Very preterm birth (,32 weeks) and SGA, reflecting fetal growth, are associated with major neonatal morbidity and mortality and may also have long-term health consequences for the child. Among treatment variables, negative effects were noted for DET with 'vanishing twin', while no effect was observed for hormonal stimulation as assessed by the number of oocytes retrieved or embryo culture time. An increased rate of placenta previa was observed after blastocyst transfer. The major strengths of the present study are that it is large and includes a complete, national cohort of singletons from assisted reproduction technology (ART). The Swedish Medical Birth Registry, that data have been cross-linked with, has been found to have high validity. Weaknesses are that certain variables of interest were not included in the IVF registry, e.g. causes of infertility, gonadotrophin dose and exact quality of the transferred embryo.
Most of the identified maternal variables are well known from earlier studies to be associated with poor obstetric outcome (Bergh et al., 1999; Schieve et al., 2002; Helmerhorst et al., 2004; Jackson et al., 2004; Källen et al., 2005a Källen et al., , 2010a . Aetiology of infertility was not recorded in the registry and was therefore not adjusted for. In one study from Australia ( Wang et al., 1994) , a higher incidence of SGA was found for unexplained infertility, and in another Australian study ( Wang et al., 2005) , a higher risk for preterm birth and LBW was noted for female factor infertility versus male factor infertility. Other studies, however, have not found any association between aetiology of infertility and obstetric outcome (Isaksson et al., 2002; Chung et al., 2006) . We could have adjusted for IVF (mainly female infertility) and ICSI (mainly male infertility) but since another Swedish study did not show any difference in obstetric outcome between IVF and ICSI (Källen et al., 2005a) , we did not include IVF technique in the analysis. However, other studies have shown an increased risk for preterm birth and LBW in IVF compared with ICSI (Ombelet et al., 2005) .
We found a negative effect on very preterm birthweight (,32 weeks) after DET with 'vanishing twins'. This is in accordance with earlier studies (Pinborg et al., 2007) . Otherwise eSET, non-eSET and DET did not affect obstetric outcomes significantly. Conflicting results have previously been reported concerning obstetric outcome for singletons after SET and DET; some studies have shown improved outcome when only one embryo was transferred (De Sutter et al., 2006; Wang et al., 2009) , while others have found no difference (Poikkeus et al., 2007) .
In the present study, we did not find that hormonal stimulation, as reflected in the number of retrieved oocytes, influenced the obstetric outcomes. A negative effect of the hormonal stimulation during IVF treatment on the obstetric outcome has been suggested to explain the poorer outcome in IVF singletons when compared with singletons in the general population, particularly as singletons from cryopreserved embryos and without further hormonal stimulation have been observed to have a better outcome (Wennerholm et al., 2009) . If a correlation exists between hormonal stimulation and an adverse outcome, it is probably not the dose of gonadotrophins per se that causes this effect but more likely the effect of the high estradiol levels, for example, on the endometrium. The number of oocytes retrieved is therefore a good indicator of that stimulatory effect, and that was the reason to include the number of oocytes retrieved in this analysis. This hypothesis is supported by a study from the USA (Chung et al., 2006) , where ovarian hyperstimulation syndrome (OHSS) (with higher number of oocytes retrieved compared with non-OHSS) was associated with a poorer obstetric outcome, as assessed as preterm delivery (,37 weeks) and/or LBW (,2500 g), also after adjusting for known confounders. A similar finding was noticed in a previous Israeli study (Abramov et al., 1998) . On the other hand, a German study investigating the effect of the dose of gonadotrophins did not find any association with the obstetric outcome (Griesinger et al., 2008) eSET was defined as transfer of one fresh embryo, when in the same treatment cycle at least one embryo was cryopreserved. Non-eSET was defined as fresh cycles when one embryo was transferred and no embryos were cryopreserved. a % refer to patients with known smoking status and known BMI. b Refers to the number of embryos frozen in the fresh cycle.
c Analysis based on the three groups only (all SET, DET-one sac, DET-vanishing twin) *P-value assessed by non-parametric test (Kruskal -Wallis).
The present study did not support that the number of embryos cryopreserved influenced obstetric outcome. The number of embryos frozen reflects the overall quality of the embryos, and was chosen as a substitute for embryo quality. The exact quality of the transferred embryo is not included in the IVF registry and could therefore not be accounted for. Few studies have addressed a possible effect of embryo quality on obstetric outcome. In a study from Austria (Ebner et al., 2001) where 146 pregnancies were analysed, no effect of embryo quality was observed on gestational age or birthweight.
We did not find that the time in embryo culture, assessed as cleavage stage or blastocyst transfer, had any significant influence on the rate of very preterm birth (,32 weeks) or SGA. Embryo culture time has been suggested to influence obstetric outcome negatively. A recent Swedish study (Källen et al., 2010b) found a higher preterm birth rate for singletons after blastocyst transfer than cleavage stages. The Källen et al. (2010b) study included children both from fresh and frozen embryos, while the present study only included children from fresh embryos. Although none of the studies found any difference in very preterm birth rate between blastocyst and cleavagestage embryos, the different inclusion criteria might well have affected the results. In an Australian study (Wang et al., 2009) , children from SET blastocysts had a slightly poorer outcome compared with children from SET cleavage stages, although not statistically significant. A recent Dutch study found that the type of culture medium significantly affected birthweight, even after adjusting for confounders.
In the present study, we found that blastocyst transfer when compared with cleavage stage transfer was an independent risk factor for placenta previa, which, to our knowledge, has not been shown before. However, several studies have shown an association between ART and placenta previa (Jackson et al., 2004; Källen et al.,2005b; Shevell et al., 2005; Romundstad et al., 2006; Schieve et al., 2007; Healy et al., 2010) embryos in the uterine cavity has been suggested as a possible cause of the increased risk of placenta previa (Romundstad et al., 2006) . Interestingly, in an Australian study, a gamete intrafallopian transfer group had a similar increased rate of placenta previa as the IVF/ICSI group, indicating no association with the embryo transfer procedure (Healy et al., 2010) . The higher risk of placenta previa after blastocyst transfer when compared with transfer of cleavage-stage embryos in our study indicates that the culture time in vitro may also interfere with early embryo development and implantation. One could speculate whether a more developed embryo, such as a blastocyst, has less time than a cleavage-stage embryo to communicate with the endometrium in order to obtain the optimal implantation zone in the uterus. Another possible mechanism may be epigenetics, which have been recognized as playing an important role in placental development and function. Disturbances of these mechanisms by ART and the possible consequences for the mother and offspring were recently reviewed by Nelissen and co-workers, describing that DNA methylation is indispensable for normal development of extraembyonic tissues, especially for the invasive behaviour of trophoblast cells . It is a matter for future research whether the increased rate of placenta previa observed in the present study after blastocyst transfer, with its prolonged embryo culture time, can be explained by epigenetic disturbances. It ought to be remembered that all these findings are based on observational data. Closer surveillance of ART pregnancies and subfertile patients with more ultrasound examinations may lead to an increased risk for the detection of an asymptomatic marginal placenta previa. This is difficult to rule out and could introduce a bias. Anyhow, the observation of an increased rate of placenta previa is an important finding. It is well known that placenta previa is a risk factor for both maternal and perinatal adverse outcome, but this was not analysed in the present study.
In conclusion, the main findings in this large registry study of singletons born after IVF in fresh cycles were that certain maternal characteristics affected the obstetric outcomes negatively. Among treatment variables, negative effects were noted for DET with 'vanishing twin'. An increased rate of placenta previa was observed after blastocyst transfer. The clinical implication of the results is to support SET in order to minimize the rate of 'vanishing twins'. The study also suggests that life-style factors, including BMI and smoking, are of importance. Universitetssjukhuset, Stockholm, Linnékliniken, Uppsala, IVF-kliniken, Falun, Hälsouniversitet, Linkö ping, Sofiahemmet, Stockholm, St Gö rans sjukhus, Stockholm.
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